---
title: "HRPC establishes a new company for internet hospitals"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233198981.md"
description: "According to the Qichacha APP, recently, Harbin HRPC Cloud Medical Internet Hospital Co., Ltd. was established, with Zhu Weidong as the legal representative and a registered capital of 1.5 million yuan. The business scope includes: internet hospital services relying on physical hospitals; internet information services for pharmaceuticals; internet information services; internet information services for medical devices, etc. Qichacha's equity penetration shows that the company is wholly owned by HRPC"
datetime: "2025-03-26T01:30:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233198981.md)
  - [en](https://longbridge.com/en/news/233198981.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233198981.md)
generator: "portal-rs"
---

# HRPC establishes a new company for internet hospitals

According to the Qichacha APP, recently, Harbin HRPC Cloud Medical Internet Hospital Co., Ltd. was established, with Zhu Weidong as the legal representative and a registered capital of 1.5 million yuan. The business scope includes: internet hospital services relying on physical hospitals; internet information services for pharmaceuticals; internet information services; internet information services for medical devices, etc. Qichacha's equity penetration shows that the company is wholly owned by HRPC

### Related Stocks

- [600829.CN](https://longbridge.com/en/quote/600829.CN.md)

## Related News & Research

- [Tencent-backed Enflame to open up 188% in Shanghai debut after $912 million IPO](https://longbridge.com/en/news/298663662.md)
- [X's Standalone Messaging App XChat Disappears From App Store](https://longbridge.com/en/news/298967675.md)
- [Lundbeck announces last patient randomized in DEEp SEA, a Phase III trial of bexicaserin in Dravet syndrome](https://longbridge.com/en/news/299012192.md)
- [Phase III TAISHAN-302 Trial Shows Tam-Peli Significantly Improves Survival in Relapsed Small-Cell Lung Cancer](https://longbridge.com/en/news/298831859.md)
- [Aignostics lance PathoSearch, un moteur de recherche visuel dédié aux cas pathologiques](https://longbridge.com/en/news/298827083.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**